Tag: Sentinel Initiative
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA monitors generic drugs after approval using real-world data, adverse event reports, and AI tools to ensure ongoing safety. Learn how systems like FAERS and Sentinel catch problems that clinical trials miss.
View more